No Data
No Data
Crescita Therapeutics Q1 Loss Widens, Revenue Rises
Crescita Therapeutics (CTX.TO), a Canadian dermatology company, on Wednesday reported a first-quarter net loss of $626,000, or $0.03 per share, wider than a loss of $273,000, or $0.01 per share, a yea
Crescita Therapeutics Brief: Q1 Revenue Was $4.996 Million
07:31 AM EDT, 05/08/2024 (MT Newswires) -- Crescita Therapeutics Brief: Q1 Revenue was $4.996 Million
Crescita Reports Third Quarter 2023 Results
Express News | Crescita Therapeutics Brief: Q2 Revenue $5.162 Million; Ending Cash Was $10,226, Down $49 for the Quarter
Crescita Reports Second Quarter 2023 Results
Anthony Edward Dobranowski Buys 15,638 Shares of Crescita Therapeutics Inc. (TSE:CTX) Stock
Crescita Therapeutics Inc. (TSE:CTX – Get Rating) Director Anthony Edward Dobranowski purchased 15,638 shares of Crescita Therapeutics stock in a transaction that occurred on Tuesday, August 16th. Th